ArticleHealth promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals2025
'Oh! It's Like Taboo': Perspectives of Religious and Community Leaders on AOD Use, Harms and Treatment in CALD Communities, Sydney.
Article in Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- 'It Takes a Village': Sociocultural Insights From a Qualitative Study on Strategies for Member Engagement and Participation in SMART Recovery.Drug and alcohol review · 2026Article
- 'Oh! It's Like Taboo': Perspectives of Religious and Community Leaders on AOD Use, Harms and Treatment in CALD Communities, Sydney.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveAlcohol and other drug (AOD) use is a growing social and health issue, and culturally appropriate treatment is important, especially for people from culturally and linguistically diverse (CALD) backgrounds. This study aimed to explore the views of religious and community leaders on AOD use and treatment in CALD communities in New South Wales, Australia.
designUsing a qualitative exploratory approach, eight religious and community leaders were purposively selected from Sub-Saharan African, North African, Middle Eastern, East Asian and Pacific Islander communities. This approach is particularly suited to contexts where little prior research exists, allowing for in-depth insights into participants' views.
resultsThe study identified four key themes in participants' perspectives on AOD use and treatment within CALD communities. First, cultural and contextual factors described how cultural and religious values influence community leaders' attitudes toward AOD. Second, community-wide impact captured the collective nature of CALD communities, where individual behaviours are seen as reflecting on the broader family and community. Third, enablers to access and engagement with AOD Services highlighted the factors that support access to and engagement with AOD services. Finally, barriers to access and engagement with AOD Services addressed the obstacles that prevent individuals from seeking treatment.
conclusionOur findings show that AOD use and harms can be influenced by contextual and cultural factors, requiring culturally appropriate and targeted interventions and strategies to prevent harm and to manage AOD treatment among CALD communities. IMPLICATIONS FOR PUBLIC HEALTH: Findings highlight the need for culturally tailored AOD prevention and treatment strategies that engage community and religious leaders to improve access, reduce stigma and increase uptake within CALD communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.